Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

BACKGROUND: Early diagnosis can significantly improve treatment outcomes for hepatocellular carcinoma (HCC) patients. Currently, the dosage of serum alpha fetoprotein (AFP) is widely used in the diagnosis of HCC, but this biomarker has low specificity and may cause false positive or false negative r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Infect Agent Cancer
Autori principali: Zhou, Jian, Zhu, Yue, Li, Yi, Liu, Kun, He, Fei, Xu, Sihuan, Li, Xin, Li, Li, Hu, Junfang, Liu, Yan
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111940/
https://ncbi.nlm.nih.gov/pubmed/33971914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13027-021-00367-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi